Why I’d dump a 10-bagger for this small-cap growth stock

Looking for growth at a reasonable price? This small-cap might be just the ticket.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

While investors should never dwell on their regrets, one that must top many lists is failing to buy shares in tonic water specialist Fevertree Drinks (LSE: FEVR) towards the end of 2014. If you’d had the skill (or good fortune) to do this, the value of your holding would have increased tenfold over the last two-and-a-half years.

Can the shares continue to rise? Sure, assuming the company can provide evidence that it has managed to build on last year’s excellent performance when it delivers half-year figures on 24 July. 

The only problem with this is the fact that 2016 was such a superb year for Fevertree. April’s full-year report highlighted a 73% increase in revenue (to £102m) and 97% rise in adjusted EBITDA (to almost £36m). Beating these figures in 2017 is no easy task and any sign that momentum is slowing could see many holders jettison the stock from their portfolios.

To further muddy the investment case, Fevertree’s popularity as a growth stock par excellence following its tendency to beat earnings estimates has left it trading on a gravity-defying 61 times forward earnings.

And given that anything over, say, two is indicative of a stock trading at a fairly high price relative to the predicted growth of the underlying company, Fevertree’s price-to earnings growth (PEG) ratio of over 5.2 also implies that the stock looks horribly expensive.

A more appealing option

If, like me, you’re put off by the possibility of Fevertree’s crown slipping, an alternative stock with decent growth credentials might be drinks wholesaler, distributor, and retailer, Conviviality (LSE: CVR). Today’s full-year results were certainly encouraging.

Thanks to a series of acquisitions (which all appear to have been integrated ahead of schedule), the £550m cap business grew revenue by 85% to £1.56bn in the year to the end of April, with adjusted pre-tax profits rocketing 111% to just under £46m.  

Broken down, the company reflected that all areas of the business had performed strongly.

A 6.4% increase in revenue (to just over £1bn) was seen at Conviviality Direct (its wholesale unit) with a total of 235 customers being added over the course of the year. 

Trading under its Wine Rack and Bargain Booze brands, revenue at its retail arm rose 6.1% to £378m. A total of 39 new franchisees joined the company last year, bringing the total number to 352 (and over 700 stores). 

In Conviviality Trading — which serves festivals and outdoor events — sales hit £146m — a rise of 1%.

Given this more-than-adequate performance, you might expect the shares to be trading at a fairly high valuation. This simply isn’t the case. Right now, you can pick up its shares at just 13 times forecast earnings. 

Remember Fevertree’s sky high PEG? Conviviality’s is 1.8 for 2017. That means investors will be getting access to earnings growth an awful lot more cheaply at the latter.

In addition to its reasonable valuation and growth potential, it’s also worth highlighting that the Crewe-based company’s shares come with a forecast 4.3% yield for the new financial year, nicely covered by profits. Given that levels of free cashflow at Conviviality climbed 349% to £51m by the end of the last financial year (which permitted the company to raise the full-year dividend by no less than 33%), I wouldn’t be surprised if the stock also becomes a core holding for many income investors in the years ahead.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Paul Summers has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Person holding magnifying glass over important document, reading the small print
Investing Articles

Just released: our top 3 small-cap stocks to consider buying in October [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

Investing Articles

How I’d use an empty Stocks and Shares ISA to aim for a £1,000 monthly passive income

Here's how using a Stocks and Shares ISA really could help those of us who plan to invest for an…

Read more »

Investing Articles

This FTSE stock is up 20% and set for its best day ever! Time to buy?

This Fool takes a look at the half-year results from Burberry (LON:BRBY) to see if the struggling FTSE stock might…

Read more »

Investing Articles

This latest FTSE 100 dip could be an unmissable opportunity to pick up cut-price stocks

The FTSE 100 has pulled back with the government’s policy choices creating some negative sentiment. But this gives us a…

Read more »

A young woman sitting on a couch looking at a book in a quiet library space.
Investing Articles

As the WH Smith share price falls 4% on annual results, is it still worth considering?

WH Smith took a hit after this morning’s results left shareholders unimpressed. With the share price down 4%, Mark Hartley…

Read more »

Investing Articles

The Aviva share price just jumped 4.5% but still yields 7.02%! Time to buy?

A positive set of results has put fresh life into the Aviva share price. Harvey Jones says it offers bags…

Read more »

Investing Articles

Can a €500m buyback kickstart the Vodafone share price?

The Vodafone share price has been a loser for investors in recent years, and the dividend has been cut. We…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Growth Shares

3 mistakes I now avoid when choosing which growth stocks to buy

Jon Smith runs through some of the lessons he's learnt the hard way over the years about what to look…

Read more »